Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Consolidated Net Profit

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹816 Cr₹588 Cr₹713 Cr₹654 Cr₹468 Cr

What is the latest Consolidated Net Profit of AJANTA PHARMA ?

The latest Consolidated Net Profit ratio of AJANTA PHARMA is ₹816 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹816 Cr
Mar2024₹588 Cr
Mar2023₹713 Cr
Mar2022₹654 Cr
Mar2021₹468 Cr

How is Consolidated Net Profit of AJANTA PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹816 Cr
38.81
Mar2024 ₹588 Cr
-17.50
Mar2023 ₹713 Cr
8.99
Mar2022 ₹654 Cr
39.81
Mar2021 ₹468 Cr -

Compare Consolidated Net Profit of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,625.9 Cr 2.3% -0% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.3%

-0%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses